| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 03/02/2005 | EP1509539A2 Novel compositions and methods for cancer |
| 03/02/2005 | EP1509515A2 Substituted 4-aryl-4h-pyrrolo 2,3-h chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 03/02/2005 | EP1509509A1 Glucagon antagonists/inverse agonists |
| 03/02/2005 | EP1509507A2 Mitotic kinesin inhibitors |
| 03/02/2005 | EP1509506A1 Pyridazine derivatives |
| 03/02/2005 | EP1509498A1 Pentafluorosulfanyl-benzoylguanidine, method for the production thereof and its utilization as medicament or diagnostic agent and medicament containing same |
| 03/02/2005 | EP1509251A2 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 03/02/2005 | EP1509250A1 Methods compositions and articles of manufacture for modulating bone growth |
| 03/02/2005 | EP1509249A2 Inclusion complexes of rosiglitazone |
| 03/02/2005 | EP1509248A1 Combination of angiotensin ii receptor blocker and beta-blocker for secondary prevention of myocardial infarction |
| 03/02/2005 | EP1509239A2 Composition and method for reducing post-prandial blood glucose |
| 03/02/2005 | EP1509237A2 Methods of treating angiogenesis, tumor growth, and metastasis |
| 03/02/2005 | EP1509233A1 Liquid formulation of decitabine and use of the same |
| 03/02/2005 | EP1509232A1 A combination of an nmda-antagonist and acetylcholine esterase inhibitors for the treatment of alzheimer's disease |
| 03/02/2005 | EP1509230A2 Method of treating cancer using kinase inhibitors |
| 03/02/2005 | EP1509225A1 Method for the use of pyranoindole derivatives to treat infection with hepatitis c virus |
| 03/02/2005 | EP1509224A1 Methods using a combination of a 3-heteroaryl-2-indolinone and a cyclooxygenase-2 inhibitor for the treatment of neoplasia |
| 03/02/2005 | EP1509222A1 Adduct of topiramate and tramadol hydrochloride and uses thereof |
| 03/02/2005 | EP1509219A1 Methods and compositions for the treatment of graft failure |
| 03/02/2005 | EP1509216A1 Active ingredient salts and esters of 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol and 3-(3-dimethylamino-1-ethyl-1-hydroxy-2-methyl-propyl)-phenol |
| 03/02/2005 | EP1509209A1 Compositions and method for transmucosal drug delivery and cryoprotection |
| 03/02/2005 | EP1509205A1 Pharmaceutical composition having a delayed active substance release, and method for the preparation thereof |
| 03/02/2005 | EP1509086A2 Htlv-i tax induced killing of p53 null cancer cells |
| 03/02/2005 | EP1326621B1 Medicinal composition and in particular its use in fluid therapy |
| 03/02/2005 | EP1296650B1 Methods and compositions for treating pain of the mucous membrane |
| 03/02/2005 | EP1241943B1 Use of polysiloxanes containing quaternary amino groups as formulation auxiliary agents, and agents containing the same |
| 03/02/2005 | EP1180018B1 Use of antiseptics in the manufacture of a pharmaceutical preparation for the prevention and treatment of infections and/ or functional tissue remodelling in the interior of the human body |
| 03/02/2005 | EP1140240B1 Injectable hyaluronic acid derivative with pharmaceuticals/cells |
| 03/02/2005 | EP1135105B1 Use of a neurologic agent for the manufacture of a medicament for the treatment of a central nervous system disorder |
| 03/02/2005 | EP1034207B1 BIODEGRADABLE LOW MOLECULAR WEIGHT TRIBLOCK POLY(LACTIDE-co-GLYCOLIDE) POLYETHYLENE GLYCOL COPOLYMERS HAVING REVERSE THERMAL GELATION PROPERTIES |
| 03/02/2005 | EP0927036B1 Transdermal therapeutical approach involving a combination of bisphosphate containing oestriol |
| 03/02/2005 | EP0910397B1 Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis |
| 03/02/2005 | EP0799311B1 Human chemokine beta-9 |
| 03/02/2005 | CN1589330A Stem cells of the islets of langerhans and their use in treating diabetes |
| 03/02/2005 | CN1589327A Plant enzymes for bioconversion |
| 03/02/2005 | CN1589280A Treatment of micro-organism infection |
| 03/02/2005 | CN1589262A Cyanoguanidine prodrugs |
| 03/02/2005 | CN1589154A Medicinal compositions containing angiotensin II receptor antagonist |
| 03/02/2005 | CN1589149A Reduced toxicity cisplatin formulations and methods for using the same |
| 03/02/2005 | CN1589141A Medicament for the treatment of viral skin and tumour diseases |
| 03/02/2005 | CN1589138A Methods and compositions to determine the chemosensitizing dose of suramin used in combination therapy |
| 03/02/2005 | CN1589136A Pharmaceutical and cosmetic compositions containing oxy group-bearing aromatic aldehydes |
| 03/02/2005 | CN1589135A Small molecule antagonists of BCL-2 family proteins |
| 03/02/2005 | CN1589134A Compositions and kits comprising a defined boron compound, methods of their preparation, and use and administration thereof |
| 03/02/2005 | CN1587270A Medicinal composition contaniing angiotensin invertase inhibitor and vitamin B |
| 03/02/2005 | CN1587269A Medicinal composition containing angiotensin II receptor antagonist and vitamin B |
| 03/02/2005 | CN1191266C Compositions for treating inflammatory response |
| 03/02/2005 | CN1191092C Multivaleng dengue virus vaccine |
| 03/02/2005 | CN1191059C Foaming emulsion for treating fatty skin |
| 03/01/2005 | US6861504 Treating thrombosis by administering a CD154 inhibitor, such as a metalloproteinase inhibitor |
| 03/01/2005 | US6861449 Method of treating neutrophil-related diseases with topical anesthetics |
| 03/01/2005 | US6861443 Drugs; modulator of a nicotinic receptor antagonist |
| 03/01/2005 | US6861441 (4(4,9-diethoxy-1-oxo-1,3-dihydro-2H-benzo(f)isoindol-2-yl) phenyl)acetic acid |
| 03/01/2005 | US6861435 3-(amino-imino-methyl)benzyl derivatives with an amide -n-sulfonylamido on the methyl of the benzyl |
| 03/01/2005 | US6861431 Detoxification of cells, tissues |
| 03/01/2005 | US6861418 Modulating protein kinase signal transduction; anticancer agents |
| 03/01/2005 | US6861409 Compounds for use in the dtreatment of growth metabolic disorders |
| 03/01/2005 | US6861406 Use of peptides or small molecules in treatment of disease, in high-throughput screening, in use of metal-binding peptides derived from sequences present in CD74-homology domain of insulin-like growth factor |
| 03/01/2005 | US6861404 Therapies for chronic renal failure |
| 03/01/2005 | US6861399 Cleaning compositions containing human serine protease T |
| 03/01/2005 | US6861256 Therapeutic and diagnostic tools for impaired glucose tolerance conditions |
| 03/01/2005 | US6861233 Method of screening for triacyglycerol hydrolase inhibitors |
| 03/01/2005 | US6861079 Fertility kit |
| 03/01/2005 | US6861069 Compression; concurrent spray drying, granulation |
| 03/01/2005 | US6861067 Hydrogel wound dressing and the method of making and using the same |
| 03/01/2005 | US6861059 Administering DP-107 or a pharmaceutically acceptable derivative thereof along with at least one therapeutic agent; synergistic |
| 03/01/2005 | US6861056 Applying composition comprising interferon gamma antibodies topically to eye to treat hyperimmune reactions such as transplant rejection, uveitis, autoimmune diseases of eye |
| 03/01/2005 | CA2196174C Use of ketoconazole and related substances in medicaments for treatment of type ii diabetes |
| 02/28/2005 | CA2479474A1 Polypeptides involved in fungal biofilm formation and polynucleotides encoding same, and uses thereof |
| 02/24/2005 | WO2005017127A2 Rna interference compositions and methods |
| 02/24/2005 | WO2005017095A2 A stable liquid probiotic composition, preparation and applications thereof |
| 02/24/2005 | WO2005016960A2 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 02/24/2005 | WO2005016370A1 Method of treating viral infections |
| 02/24/2005 | WO2005016345A1 Multivitamin syrup for children or young adults |
| 02/24/2005 | WO2005016334A1 Compositions and methods involving the combination of a thromboxane a2 receptor antagonist and an inhibitor of cyclooxigenase-1 |
| 02/24/2005 | WO2005016271A2 Composition comprising a zeolite compound for treatment of diseases |
| 02/24/2005 | WO2005016270A2 Methods for treatment of dermatological conditions |
| 02/24/2005 | WO2005016265A2 Method for promoting bone growth |
| 02/24/2005 | WO2005016235A2 Combined use of impdh inhibitors with toll-like receptor agonists |
| 02/24/2005 | WO2005016231A2 Agents and methods for treatment of disease by oligosaccharide targeting agents |
| 02/24/2005 | WO2005016114A2 Generation of living tissue constructs in vivo using a mold |
| 02/24/2005 | WO2005009338A3 Method of inhibiting atf/creb and cancer cell growth and pharmaceutical compositions for same |
| 02/24/2005 | WO2005004880A8 Vaginal compositions for treating pelvic tissue infections and traumas |
| 02/24/2005 | WO2004113375A3 Antimicrobial compositions and uses thereof |
| 02/24/2005 | WO2004110492A3 Composition comprising triptans and nsaids |
| 02/24/2005 | WO2004075907A9 Salutary compositions consisting of fungi containing lipids and thiocyanates |
| 02/24/2005 | WO2004066990B1 Methods of treating lower urinary tract disorders using sodium channel modulators |
| 02/24/2005 | WO2004066987B1 Use of sodium channel modulators for treating gastrointestinal tract disorders |
| 02/24/2005 | WO2004024088A3 Design of chemokine analogs for the treatment of human diseases |
| 02/24/2005 | WO2004009064A8 Use of neurotoxic substances for the production of a means for the treatment of joint pain and method for application of said means |
| 02/24/2005 | WO2004009020A3 Pyrrolopyrimidine thionucleoside analogs as antivirals |
| 02/24/2005 | WO2003102206A3 Sgk and nedd used as diagnostic and therapeutic targets |
| 02/24/2005 | WO2003099851A3 Methods and compositions for inhibiting hiv replication |
| 02/24/2005 | WO2003061362A3 Methods and compositions for treating polycystic ovary syndrome |
| 02/24/2005 | WO2003053921A3 Mutant proteinase inhibitors and uses thereof |
| 02/24/2005 | WO2003037400A3 Methods and device compositions for the recruitment of cells to blood contacting surfaces in vivo |
| 02/24/2005 | WO2003018758A3 Reagents and methods for smooth muscle therapies |
| 02/24/2005 | US20050043788 Drug-eluting stent |
| 02/24/2005 | US20050043773 Methods of improving the safety of zonisamide therapy |
| 02/24/2005 | US20050043705 Methods of using zonisamide as an adjunctive therapy for partial seizures |